Should I Buy INLX? INLX 2026 Analysis

Should You Buy Intellinetics Inc (INLX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

7.950

1 Day change

-5.47%

52 Week Range

15.720

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: there is no strong proprietary buy signal, upside looks modest, and fundamentals are weakening.
Price is sitting near first resistance (R1 ~8.31), which caps immediate reward unless it breaks out cleanly.
With revenue down YoY and the company still losing money, the risk/reward isn’t compelling for a “buy now” decision.

Technical Analysis

Trend/Momentum: MACD histogram is positive (0.0518) but contracting, implying bullish momentum is fading rather than accelerating.
RSI(6) ~60: mild bullish/neutral—no oversold “snap-back” setup.
Moving averages: converging MAs typically signal consolidation/indecision rather than a strong trend.
Key levels: Pivot 8.131; Support S1 7.954 (then S2 7.845); Resistance R1 8.308 (then R2 8.417). Current price 8.26 is close to R1, limiting near-term upside unless it breaks above.
Pattern-based projection: similar-pattern stats suggest ~70% chance of small gains (next day +0.62%, next week +2.64%, next month +3.13%)—positive but not strong enough to override weak fundamentals.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Gross margin improved to 56.29% (+2.59% YoY), indicating better unit economics despite softer revenue.
- Technicals are not bearish: MACD remains above zero and RSI is not overbought.
- No notable hedge fund/insider selling pressure indicated (both neutral).

Neutral/Negative Catalysts

- No news in the recent week: lack of catalysts reduces the odds of a fast upside move.
- Price is near resistance (R1 ~8.308), increasing the chance of a stall/pullback if buyers don’t push through.
- Fundamentals are trending down (revenue down YoY; continued net losses), which can weigh on sentiment and limit sustained rallies.
- No recent congress trading data available (no supportive “influential buyer” signal).

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 4,001,445 (down -12.82% YoY) — top-line contraction.
Net income: -369,765 (down -5.88% YoY) — still unprofitable.
EPS: -0.08 (down -11.11% YoY) — earnings trend weakening.
Gross margin: 56.29% (up +2.59% YoY) — a bright spot, but not yet translating into profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target change data provided, so there is no visible recent Wall Street upgrade/downgrade trend to support a “buy now” call.
Wall Street pros/cons view (based on available data only): Pros—improving gross margin; Cons—declining revenue and ongoing losses with no near-term catalyst.

Analyst Rating

Wall Street analysts forecast INLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INLX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 8.410

Low

Averages

High